Novavax
Novavax, Inc. is a clinical-stage vaccine company headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden. Novavax is a public company that trades under the symbol "NVAX". In June 2013, Novavax acquired the Matrix-MTM adjuvant platform with the purchase of Swedish company Isconova AB.
Wikipage redirect
primaryTopic
Novavax
Novavax, Inc. is a clinical-stage vaccine company headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden. Novavax is a public company that trades under the symbol "NVAX". In June 2013, Novavax acquired the Matrix-MTM adjuvant platform with the purchase of Swedish company Isconova AB.
has abstract
Novavax, Inc. is a clinical-st ...... f Swedish company Isconova AB.
@en
founding year
industry
location city
państwo
number of employees
product
type
Link from a Wikipage to an external page
Wikipage page ID
42,631,881
Wikipage revision ID
744,866,096
area served
assets
name
revenue
sec cik
traded as
subject
point
39.1371167 -77.2258056
comment
Novavax, Inc. is a clinical-st ...... f Swedish company Isconova AB.
@en
label
Novavax
@en
lat
3.91371167e+1
long
-7.72258056e+1
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Novavax, Inc.
@en